Western Asset High Income Opportunity Fund Inc is a US-based company operating in industry. The company is headquartered in New York City, New York. Western Asset High Income Opportunity Fund Inc. (the Fund) is a diversified, closed-end management investment company. The Fund seeks high current income. Capital appreciation is a secondary objective. In seeking to fulfill its investment objectives, the Fund invests, under normal market conditions, at least 80% of its net assets in high-yield securities and up to 20% in common stock equivalents, including options, warrants and rights. The Fund invests in sectors, such as consumer cyclical, communications, energy, finance, consumer non-cyclical, transportation, EM government, capital goods, and other. The Fund’s investment manager is Franklin Templeton Fund Adviser, LLC.
Western Asset High Income Opportunity Fund Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Ironwood Pharmaceuticals Inc 주요 수익원은 Human Therapeutics이며, 최신 수익 발표에서 수익은 296,151,000입니다. 지역별로는 United States이 Ironwood Pharmaceuticals Inc의 주요 시장이며, 수익은 289,339,527입니다.
Western Asset High Income Opportunity Fund Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 Ironwood Pharmaceuticals Inc의 순손실은 $0입니다.
Western Asset High Income Opportunity Fund Inc에 부채가 있나요?
no, Ironwood Pharmaceuticals Inc의 부채는 0입니다.
Western Asset High Income Opportunity Fund Inc의 발행 주식은 몇 주인가요?